PDL BioPharma, Inc. (PDLI) Tops Q2 EPS by 4c
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q2 EPS of $0.53 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)